These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: [New antiplatelet agents]. Author: Beer JH. Journal: Praxis (Bern 1994); 1999 May 06; 88(19):853-60. PubMed ID: 10409883. Abstract: Aspirin has set the gold standard for platelet inhibition in prophylaxis and treatment of cardiovascular diseases. Invasive techniques and novel platelet-inhibitors have fundamentally changed therapeutic approaches to antithrombotic treatment and further diversification is to be expected in the future. Three trends are essentially obvious: 1) the combination of established inhibitors such as aspirin with ticlopidine or clopidogrel, 2) the use of new IIb/IIa antagonists in various molecular forms, pharmacologies and doses and 3) the combination of established platelet-inhibitors with theses novel IIIb/IIIa antagonists.[Abstract] [Full Text] [Related] [New Search]